NEW YORK (GenomeWeb) – Luminex reported after the close of the market Monday a 2 percent rise in its first quarter revenues, an increase helped by a 17 percent jump in assay revenues.

For the three-month period ended March 31, Luminex's revenues rose to $57.7 million from $56.6 million in the same period a year earlier, topping Wall Street analysts' average estimate of $56.5 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.